From The Medical Journal of Australia:
Supplement
Characterising novel pathways to schizophrenia
Ian B Hickie and Patrick D McGorry — Med J Aust 2009; 190 (4): S5-S6.
New directions in the epidemiology of schizophrenia
John J McGrath and Ezra S Susser — Med J Aust 2009; 190 (4): S7-S9.
Brain changes during the onset of schizophrenia: implications for neurodevelopmental theories
Stephen J Wood, Christos Pantelis, Alison R Yung, Dennis Velakoulis and Patrick D McGorry — Med J Aust 2009; 190 (4): S10-S13.
Synapse formation and regression in the cortex during adolescence and in schizophrenia
Maxwell R Bennett — Med J Aust 2009; 190 (4): S14-S16.
Are common childhood or adolescent infections risk factors for schizophrenia and other psychotic disorders?
Ian B Hickie, Richard Banati, Catherine H Stewart and Andrew R Lloyd — Med J Aust 2009; 190 (4): S17-S21.
Amphetamine psychosis: a model for studying the onset and course of psychosis
Daniel F Hermens, Dan I Lubman, Philip B Ward, Sharon L Naismith and Ian B Hickie — Med J Aust 2009; 190 (4): S22-S25.
Therapeutic signposts: using biomarkers to guide better treatment of schizophrenia and other psychotic disorders
Richard Banati and Ian B Hickie — Med J Aust 2009; 190 (4): S26-S32.
A clinical trials agenda for testing interventions in earlier stages of psychotic disorders
Patrick D McGorry, Alison R Yung, Christos Pantelis and Ian B Hickie — Med J Aust 2009; 190 (4): S33-S36.
Oestrogen — a new treatment approach for schizophrenia?
Jayashri Kulkarni — Med J Aust 2009; 190 (4): S37-S38.
Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care
Tim J R Lambert and John W Newcomer — Med J Aust 2009; 190 (4): S39-S42.
Mental health policy — stumbling in the dark?
David W Crosbie — Med J Aust 2009; 190 (4): S43-S45.
Also see:
Schizophrenia: It's Not Just "in The Genes"; The Environment May Also Matter
